跳至主要内容
临床试验/NCT01101373
NCT01101373已完成不适用

Bilateral Anterior Capsulotomy For Intractable Depression

University of British Columbia1 个研究点 分布在 1 个国家开始时间: 2000年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
试验地点
1

研究概览

简要总结

This study will report on the outcome of a clinical program, operational since 1998, that has used surgery targeting an emotional pathway in the brain in the treatment of severe depressive illness that has failed to respond to all other available interventions. Benefit from surgery was anticipated on the basis that the lesion (bilateral anterior capsulotomy) is a well established surgical target for treating severe treatment resistant depression.

详细描述

Since 1998 bilateral anterior capsulotomy (BAC) has been available to patients in British Columbia Canada who have treatment refractory severe depressive illness. This study will report on the outcome of patients who have received this intervention. BAC is achieved by stereotactic radiofrequency lesioning. To date 8 patients have received BAC. For all patients there is follow-up data of at least 24 months. The purpose of this retrospective study is to report on the surgical protocol and to demonstrate the efficacy and safety of BAC in severe depression.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Severe treatment resistant depression of at least 5 years duration
  • older than 18 years

排除标准

  • Comorbid organic mental disorder
  • Delusional disorder
  • Substance disorder
  • Neurological disease
  • Cluster B personality disorder

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Trevor Hurwitz

Principal Investigator

University of British Columbia

研究点 (1)

Loading locations...

相似试验